London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ticker......................
https://businesscann.com/
MGC Pharmaceuticals Ltd ....... 99.34 million AUD
Cellular Goods PLC ....... 37.93 million GBP
Kanabo Group PLC ........... 46.78 million GBP
Apollon Formularies
@apollon_uk
·
32m
(4/4) Having the first patients at the new International Cancer and Chronic Pain Institute is momentous for the Company, and its founder, CEO and Chairman, Dr. Stephen Barnhill. Read his comments below:
Apollon Formularies
@apollon_uk
·
35m
(3/4) The #medicalcannabis #cancer treatments provided will exclusively be #Apollon’s products, which have recently shown to be highly effective in killing cancer cells in pre-clinical third-party, independent testing at BIOENSIS laboratories
Apollon Formularies
@apollon_uk
·
42m
(2/4) The Jamaican and international patients will be treated by experienced specialist physicians led by Dr Margaret Dingle Spence, a specialist in Clinical #Oncology, Radiation Therapy, and Palliative Care Medicine.
Apollon Formularies
@apollon_uk
·
49m
(1/4) Apollon Formularies is pleased to announce that the new International Cancer and Chronic Pain Institute is now officially open, welcoming the first cancer patients to be treated with #Apollon’s proprietary
Nice one Tro................... thanks................
Apollon Formularies has begun treating cancer patients at Kingston, Jamaica, centre
"This is a huge milestone for Apollon,” said Stephen Barnhill, Apollon chairman and chief executive
Apollon Formularies (AQSE:APOL) PLC said it has started treating its first cancer patients using cannabis-based therapies at the International Cancer and Chronic Pain Institute in Kingston, Jamaica.
With expertise in cannabinoid medicine, the team will be led by Dr Margaret Dingle Spence.
"This is a huge milestone for Apollon,” said Stephen Barnhill, Apollon chairman and chief executive.
"After many years of researching, developing, manufacturing and testing these proprietary Apollon medical cannabis formulations, we are so proud to announce that they are now available to cancer patients by physician prescription at the International Cancer and Chronic Pain Institute."
The company’s formulations were recently shown to be highly effective in killing cancer cells in a pre-clinical assessment by BIOENSIS in the US using state-of-the-art 3D cell culture testing.
Apollon Formularies
@apollon_uk
·
45m
Apollon Formularies - First Cancer Patients Treated
First Cancer Patients Treated with Apollon Formularies Products at The International Cancer and Chronic Pain Institute
https://aquis.eu/aquis-stock-exchange/for-investors/announcements?view_news_id=3351456
Apollon Formularies
@apollon_uk
·
32m
Stephen D. Barnhill, Jr. Chief Operating Officer stated:
"I am so proud of our entire team in Jamaica who have accomplished this incredible achievement. Their passion for helping patients and dedication to reaching this goal has now become a reality."
Apollon Formularies
@apollon_uk
·
10m
Stene Jacobs, Chief Operating Officer for European and African Operations, commented: "I am delighted to see the progress we have made as a company in Jamaica. Our goal as a company is to now expand this success into other markets globally"
Good news Andrew........................ LOL
International Cancer and Chronic Pain Institute Officially Opens to Patients
· First cancer patients treated with Apollon's Medical Cannabis Products
· Apollon's Medical Cannabis Products were recently shown to be highly effective in killing cancer cells
· Clinical trials to be performed on Apollon's proprietary Medical Cannabis Products
https://www.investegate.co.uk/apollon-formularies--apol-/rns/first-cancer-patients-treated/202112090700070520V/
First cancer patients now being treated........
Tweed removed why?
Apollon Formularies
@apollon_uk
·
2m
Apollon’s ambition is to become the premier global medical cannabis company legally licensed to develop successful personalised clinical treatments utilising artificial intelligence on clinical trial patient data
https://twitter.com/apollon_uk
https://twitter.com/apollon_uk/status/1467786762349158400
Worldwide, breast cancer is the most common cancer in women and accounts for the most cancer related deaths. In 2019, the breast cancer market totalled over US$20 billion, with 68% of therapies sold targeting HER2 or CDK4/6.
EPISODE #119 Medical Cannabis in Jamaica with Dr. Stephen Barnhill & Rod Mcllree from Apollon Formu
146 viewsJul 5, 2021
https://www.youtube.com/watch?v=6VxTAboZevo
Awaiting news on AGM....................
https://www.aquis.eu/aquis-stock-exchange/member?securityidaqse=APOL
AGM should be over by now......................
Apollon Formularies
@apollon_uk
·
10m
We expect to negotiate joint license agreement whereby AI Pharma exclusively use Apollon's medical cannabis formulations in combined product in US and Canada, Apollon exclusively use Aion's medicinal (non-psilocybin) mushroom combined product in Europe and Jamaica, where legal.